The most comprehensive diabetes knowledge base online. Understand your diabetes. Know your supplies. Make better decisions.
MDS Diabetes
Diabetes
Encyclopedia
Shop Supplies β†’
Researchβœ“ Reviewed for accuracy

Insulin Pumps Boost Quality of Life in Type 1 Diabetes

Adults with type 1 diabetes using insulin pumps reported higher treatment satisfaction and better glucose control than those on daily injections.

M
MDS Diabetes Team
Β·6 min read
𝕏f
Key takeaways
  • βœ“People with type 1 diabetes who used an insulin pump had higher treatment satisfaction, better time-in-range, and fewer dangerous low blood sugar episodes compared to those using multiple daily injections.
Quick specs
JournalJournal of diabetes and its complications
Year2026
AuthorsBriganti, Lanza, Renzelli
PMID41240449
DOI10.1016/j.jdiacomp.2025.109215

What This Study Found

A new study found that adults with type 1 diabetes who used an insulin pump (also called continuous subcutaneous insulin infusion, or CSII) reported feeling more satisfied with their treatment and more accepting of their condition than those who used multiple daily injections (MDI). Pump users also spent more time with their blood sugar in a healthy range and had fewer episodes of low blood sugar. Importantly, people who felt more satisfied with their treatment also tended to have better overall glucose control.

Why This Matters for Your Daily Life

Managing type 1 diabetes is a 24/7 job. It touches nearly every part of daily life β€” from what you eat to how well you sleep. This study highlights something that many people with diabetes already suspect: the tools you use to manage your diabetes can affect not just your blood sugar numbers, but also how you feel about living with the condition.

The researchers looked at 69 adults with type 1 diabetes. About half used an insulin pump and half used injections. Even though both groups were similar in age, sex, and how long they had lived with diabetes, the pump users reported:

  • Higher treatment satisfaction scores
  • Better acceptance of their diabetes
  • More time with blood sugar in the target range (Time in Range, or TIR)
  • Less time with dangerously low blood sugar levels

What Is Time in Range β€” and Why Does It Matter?

Time in Range (TIR) measures the percentage of time your blood sugar stays between 70 and 180 mg/dL. Experts recommend spending at least 70% of the day in this range. The study found that pump users hit this target more consistently. Less time spent low means fewer hypoglycemia episodes β€” which can cause shakiness, confusion, and in serious cases, unconsciousness.

Satisfaction and Blood Sugar Are Linked

One of the most interesting findings was that people who felt more satisfied with their treatment also had better blood sugar control β€” regardless of whether they were using a pump or injections. This connection held up even after the researchers accounted for treatment type. In other words, feeling good about how you manage your diabetes may actually help you manage it better.

Important Limits to Keep in Mind

This was a relatively small study β€” just 69 people β€” and it looked at a single point in time, so we can't say for certain that pumps cause better quality of life. It's possible that people who were already doing well were more likely to use a pump. Still, the findings add to a growing body of evidence supporting diabetes technology as a meaningful tool.

Talking to Your Care Team

If you're currently using multiple daily injections and wondering whether an insulin pump or continuous glucose monitor (CGM) might be right for you, this research gives you good reason to bring it up with your doctor. Diabetes technology isn't one-size-fits-all, but the evidence suggests it can make a real difference β€” in your numbers and in your day-to-day wellbeing.

At mdsdiabetes.com, you'll find a range of CGM supplies, pump accessories, and diabetes management tools to help support whatever approach works best for you.

Key Takeaway: People with type 1 diabetes who used an insulin pump had higher treatment satisfaction, better time-in-range, and fewer dangerous low blood sugar episodes compared to those using multiple daily injections.

Citation: Briganti, Lanza, Renzelli (2026). Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes. Journal of Diabetes and Its Complications. PMID: 41240449. DOI: 10.1016/j.jdiacomp.2025.109215

References & Sources

Editorial note
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 7, 2026 by the MDS Diabetes editorial team.
What to do next
πŸ“š
Read more Research articles
Explore all guides in this topic
β†’
πŸ›’
Shop related supplies at MDS
FSA/HSA eligible Β· Free shipping $60+
β†’
Topics
type 1 diabetesinsulin pumpcontinuous glucose monitortime in rangequality of lifeblood sugar managementresearchclinical studypeer reviewed

Related articles

Ask Mila about diabetes